Arterial hypertension and COVID-19 infections: A brief commentary

Czech version

Authors: Jiří Widimský
Authors‘ workplace: Centrum pro hypertenzi, III. interní klinika VFN a 1. LF UK Praha
Published in: Vnitř Lék 2020; 66(3): 104-106
Category:

Overview

The issue of hypertension/antihypertensive treatment in patients with COVID-19 infection is discussed in the commentary.

Keywords:

hypertension – COVID-19 – Antihypertensive drugs

Sources

1. Danser J, Epstein M, Batlle Renin -Angiotensin D. System Blockers and the COVID-19 Pandemic At Present There Is No Evidence to Abandon Renin -Angiotensin System Blockers. Hypertension June 2020/ DOI: 10.1161/HYPERTENSIONAHA.120.15082.

2. Esler M, Esler D. Can angiotensin receptor -blocking drug perhaps be harmful in the COVID-19 pandemic? J Hypertension, 2020, 38, 781–782.

3. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V and Desormais I. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Journal of hypertension. 2018; 36: 1953–2041.

4. Diagnostické a léčebné postupy u arteriální hypertenze - verze 2017. Doporučení České společnosti pro hypertenzi J. Widimský jr., J. Filipovský, J. Ceral, R. Cífková, A. Linhart, V. Monhart, H. Rosolová, J. Seidlerová Mlíková, M. Souček, J. Špinar, V.Tesař, J. Vítovec T. Zelinka. Hypertenze a kardiovaskulární prevence, 2018, supplement, str. 1–22.